Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Extended Post-Operative Oral Tranexamic Acid Dosing After ACL Reconstruction: A Multicenter Randomized Controlled Trial (SM25091)

NCT07880743 is registered in ClinicalTrials.gov with Dave Bernholt as lead sponsor.

NCT NCT07880743
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07880743 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Extended Post-Operative Oral Tranexamic Acid Dosing After ACL Reconstruction: A Multicenter Randomized Controlled Trial (SM25091)
Lead sponsor
Dave Bernholt
Phase
Phase 3
Overall status
Not yet recruiting
Start date
November 30, 2026
Completion date
December 31, 2028
Enrollment
100 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

anterior cruciate ligament injuries, anterior cruciate ligament rupture, pain, postoperative